2023
DOI: 10.1038/s41594-022-00867-8
|View full text |Cite
|
Sign up to set email alerts
|

Structural basis of CHMP2A–CHMP3 ESCRT-III polymer assembly and membrane cleavage

Abstract: HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers. L'archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d'enseignement et de recherche français ou étrangers, des labor… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
30
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 28 publications
(34 citation statements)
references
References 103 publications
4
30
0
Order By: Relevance
“…In contrast, CHMP3-NS3-FP does not affect VPS4 activity, suggesting that its structure is compatible with VPS4 function. Blocking auto-cleavage of CHMP4B and CHMP2A by NS3 with Glecaprevir does not fully inhibit VLP release and notably blocking auto-cleavage of CHMP3-NS3-FP has no effect on VLP release, but enhances the effect of CHMP2A-NS3-FP, in agreement with the reported synergy of CHMP2A-CHMP3 on HIV-1 budding [53] and CHM2A-CHMP3 heteropolymer formation in vitro [34]. Interestingly, a VPS4B mutant that was previously shown to slow down the kinetics of ESCRT-III disassembly in vitro [64] shows a similar reduction in VLP release as inhibition of CHMP4B and CHMP2A auto-cleavage.…”
Section: Discussionsupporting
confidence: 80%
See 2 more Smart Citations
“…In contrast, CHMP3-NS3-FP does not affect VPS4 activity, suggesting that its structure is compatible with VPS4 function. Blocking auto-cleavage of CHMP4B and CHMP2A by NS3 with Glecaprevir does not fully inhibit VLP release and notably blocking auto-cleavage of CHMP3-NS3-FP has no effect on VLP release, but enhances the effect of CHMP2A-NS3-FP, in agreement with the reported synergy of CHMP2A-CHMP3 on HIV-1 budding [53] and CHM2A-CHMP3 heteropolymer formation in vitro [34]. Interestingly, a VPS4B mutant that was previously shown to slow down the kinetics of ESCRT-III disassembly in vitro [64] shows a similar reduction in VLP release as inhibition of CHMP4B and CHMP2A auto-cleavage.…”
Section: Discussionsupporting
confidence: 80%
“…VPS4 was suggested to constantly remodel ESCRT-III in vivo [47] consistent with VPS4-catalyzed ESCRT-III filament remodeling in vitro [48, 49]. Notably CHMP2A-CHMP3 filament remodeling into dome-like end-caps was suggested to constrict membrane necks from fixed diameters of 45 to 55 nm down to the point of fission [34, 48, 50].…”
Section: Introductionmentioning
confidence: 91%
See 1 more Smart Citation
“…S3D). This suggests that ESCRT-III proteins in S. acidocaldarius form layered composite structures, not heteropolymers like their eukaryotic counterparts Vps2 and Vps24 ( 43 ). CdvB1 consistently formed two rings flanking CdvB2, while CdvB2 was found either assembled into a single diffuse structure overlying the central CdvB ring or into two flanking rings that are too close to easily resolve using STED.…”
Section: Discussionmentioning
confidence: 99%
“…When exposed to model membranes in vitro, ESCRT-III proteins can shape membranes into structures with zero 31,32 , positive 22,29,[33][34][35][36] or negative curvature 31,32,[37][38][39] . We recently demonstrated how a pair of human ESCRT-III proteins, CHMP1B and IST1, assemble into helical filaments that act in sequence to remodel membranes into high-curvature nanotubes with an inner diameter of only roughly Supplementary Information for full details).…”
Section: Escrt-iii Protein Chmp1b α1 Induces a Furrow In The Bilayermentioning
confidence: 99%